{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:58:13Z","timestamp":1793051893200,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s12640-019-00120-z","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T20:32:44Z","timestamp":1572035564000},"page":"198-209","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Neuroprotective Effect of Quercetin in Combination with Piperine Against Rotenone- and Iron Supplement\u2013Induced Parkinson\u2019s Disease in Experimental Rats"],"prefix":"10.1007","volume":"37","author":[{"given":"Shakshi","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadga","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2780-6632","authenticated-orcid":false,"given":"Shamsher","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,25]]},"reference":[{"key":"120_CR1","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1124\/jpet.102.034728","volume":"302","author":"RK Bhardwaj","year":"2002","unstructured":"Bhardwaj RK, Glaeser H, Becquemont L, Klotz U, Gupta SK, Fromm MF (2002) Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther 302:645\u2013650","journal-title":"J Pharmacol Exp Ther"},{"key":"120_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1353-8020(03)00022-1","volume":"9","author":"I Bodis-Wollner","year":"2003","unstructured":"Bodis-Wollner I (2003) Neuropsychological and perceptual defects in Parkinson\u2019s disease. Parkinsonism Relat Disord 9:83\u201389","journal-title":"Parkinsonism Relat Disord"},{"key":"120_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.freeradbiomed.2013.01.018","volume":"62","author":"DT Dexter","year":"2013","unstructured":"Dexter DT, Jenner P (2013) Parkinson disease: from pathology to molecular disease mechanisms. Free Radic Biol Med 62:132\u2013144","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"120_CR4","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","volume":"68","author":"E Dorsey","year":"2007","unstructured":"Dorsey E, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68(5):384\u2013386","journal-title":"Neurology"},{"key":"120_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70\u201377","journal-title":"Arch Biochem Biophys"},{"issue":"4-5","key":"120_CR6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0197-0186(03)00037-8","volume":"43","author":"KM Erikson","year":"2003","unstructured":"Erikson KM, Aschner M (2003) Manganese neurotoxicity and glutamate-GABA interaction. Neurochem Int 43(4-5):475\u2013480","journal-title":"Neurochem Int"},{"key":"120_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","volume":"126","author":"LC Green","year":"1982","unstructured":"Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126:131\u2013138","journal-title":"Anal Biochem"},{"issue":"11","key":"120_CR8","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.neurol.2015.07.011","volume":"171","author":"P Gubellini","year":"2015","unstructured":"Gubellini P, Kachidian P (2015) Animal models of Parkinson\u2019s disease: an updated overview. Rev Neurol 171(11):750\u2013761","journal-title":"Rev Neurol"},{"issue":"2","key":"120_CR9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/j.1471-4159.1991.tb08170.x","volume":"56","author":"EC Hirsch","year":"1991","unstructured":"Hirsch EC, Brandel JP, Galle P, Javoy-Agid F, Agid Y (1991) Iron and aluminum increase in the substantia nigra of patients with Parkinson\u2019s disease: an X-ray microanalysis. J Neurochem 56(2):446\u2013451","journal-title":"J Neurochem"},{"issue":"2","key":"120_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/2231-0738.84204","volume":"1","author":"K Karunanithi","year":"2011","unstructured":"Karunanithi K, Annadurai A, Krishnamoorthy M, Elumalai P, Manivasagam T (2011) 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine is a potent neurotoxin: Gamma-tocopherol recuperate behavior, dopamine, and oxidative stress on Parkinsonic mice. Int J Nutr Pharmacol Neurol Dis 1(2):139\u2013145","journal-title":"Int J Nutr Pharmacol Neurol Dis"},{"issue":"2-3","key":"120_CR11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ejphar.2011.11.030","volume":"674","author":"P Kumar","year":"2012","unstructured":"Kumar P, Kalonia H, Kumar A (2012) Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity. Eur J Pharmacol 674(2-3):265\u2013274","journal-title":"Eur J Pharmacol"},{"key":"120_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/toxsci\/66.1.139","volume":"66","author":"SM Lasley","year":"2002","unstructured":"Lasley SM, Gilbert ME (2002) Rat hippocampal glutamate and GABA release exhibit biphasic effects as a function of chronic lead exposure level. Toxicol Sci 66:139\u2013147","journal-title":"Toxicol Sci"},{"key":"120_CR13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"120_CR14","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1073\/pnas.0501703102","volume":"102","author":"AB Patel","year":"2005","unstructured":"Patel AB, de Graaf RA, Mason GF, Rothman DL, Shulman RG, Behar KL (2005) The contribution of GABA to glutamate\/glutamine cycling and energy metabolism in the rat cortex in vivo. Proc Natl Acad Sci U S A 102:5588\u20135593","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"120_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.neuint.2006.02.003","volume":"49","author":"K Radad","year":"2006","unstructured":"Radad K, Rausch WD, Gille G (2006) Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration. Neurochem Int 49(4):379\u2013386","journal-title":"Neurochem Int"},{"issue":"2","key":"120_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0166-4328(02)00376-5","volume":"141","author":"NR Rustay","year":"2003","unstructured":"Rustay NR, Wahlsten D, Crabbe JC (2003) Influence of task parameters on rotarod performance and sensitivity to ethanol in mice. Behav Brain Res 141(2):237\u2013249","journal-title":"Behav Brain Res"},{"issue":"3","key":"120_CR17","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s12640-015-9519-y","volume":"27","author":"J Segura-Aguilar","year":"2015","unstructured":"Segura-Aguilar J, Kostrzewa RM (2015) Neurotoxin mechanisms and processes relevant to Parkinson\u2019s disease: an update. Neurotox Res 27(3):328\u2013354","journal-title":"Neurotox Res"},{"issue":"7","key":"120_CR18","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.4103\/1673-5374.211194","volume":"12","author":"S Singh","year":"2017","unstructured":"Singh S, Jamwal S, Kumar P (2017) Neuroprotective potential of quercetin in combination with piperine against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced neurotoxicity. Neural Regen Res 12(7):1137\u20131144","journal-title":"Neural Regen Res"},{"key":"120_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1083\/jcb.32.2.415","volume":"32","author":"GL Sottocasa","year":"1967","unstructured":"Sottocasa GL, Kuylenstierna B, Ernster L, Bergstrand A (1967) An electron-transport system associated with the outer membrane of liver mitochondria a biochemical and morphological study. J Cell Biol 32:415\u2013438","journal-title":"J Cell Biol"},{"issue":"1","key":"120_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00204-015-1579-5","volume":"90","author":"M Valko","year":"2016","unstructured":"Valko M, Jomova K, Rhodes CJ, Ku\u010da K, Musilek K (2016) Redox-and non-redox-metal-induced formation of free radicals and their role in human disease. Arch Toxicol 90(1):1\u201337","journal-title":"Arch Toxicol"},{"issue":"1","key":"120_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J (2015) Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodegener 4(1):19\u201328","journal-title":"Transl Neurodegener"},{"issue":"8","key":"120_CR22","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/sj.bjp.0707167","volume":"150","author":"PS Whitton","year":"2007","unstructured":"Whitton PS (2007) Inflammation as a causative factor in the aetiology of Parkinson\u2019s disease. Br J Pharmacol 150(8):963\u2013976","journal-title":"Br J Pharmacol"},{"key":"120_CR23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/0076-6879(67)10043-8","volume":"10","author":"CA Yu","year":"1967","unstructured":"Yu CA, Yu L (1967) Preparations of succinate\u2014cytochrome c reductase and the cytochrome bc 1 particle, and reconstitution of succinate-cytochrome c reductase. Methods Enzymol 10:216\u2013225","journal-title":"Methods Enzymol"},{"key":"120_CR24","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3389\/fnins.2017.00657","volume":"11","author":"L Yu","year":"2017","unstructured":"Yu L, Wang X, Chen H, Yan Z, Wang M, Li Y (2017) Neurochemical and behavior deficits in rats with iron and rotenone co-treatment: role of redox imbalance and neuroprotection by biochanin A. Front Neurosci 11:657\u2013668","journal-title":"Front Neurosci"},{"issue":"2","key":"120_CR25","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.lwt.2012.07.036","volume":"50","author":"Z Zarai","year":"2013","unstructured":"Zarai Z, Boujelbene E, Salem NB, Gargouri Y, Sayari A (2013) Antioxidant and antimicrobial activities of various solvent extracts, piperine and piperic acid from Piper nigrum. LWT Food Sci Technol 50(2):634\u2013641","journal-title":"LWT Food Sci Technol"},{"key":"120_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.09.012","volume":"155","author":"FA Zucca","year":"2017","unstructured":"Zucca FA, Segura-Aguilar J, Ferrari E, Mu\u00f1oz P, Paris I, Sulzer D, Sarna T, Casella L, Zecca L (2017) Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson\u2019s disease. Prog Neurobiol 155:96\u2013119","journal-title":"Prog Neurobiol"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-019-00120-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-019-00120-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-019-00120-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T03:43:31Z","timestamp":1611632611000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-019-00120-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,25]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["120"],"URL":"https:\/\/doi.org\/10.1007\/s12640-019-00120-z","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,25]]},"assertion":[{"value":"7 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"These animals were fed with standard diet in accordance with Institutional Animal Ethics Committee (IAEC) guidelines. The experimental protocol was reviewed and approved by the Institutional Animal Ethics Committee (ISFCP\/IAEC\/CPCSEA\/2018\/382) and performed in accordance with Indian National Science Academy (INSA) and Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) for the use and care of experimental animals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}